Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05116852 · ClinicalTrials.gov registry record
Community and Familial Impacts of the Opioid Crisis
A clinical trial, sponsored by Cambridge Health Alliance.
- Completed
- Registry status
- 578
- Enrollment target
NCT05116852: Completed study, sponsored by Cambridge Health Alliance.
NCT05116852 is a clinical trial that has completed, run by Cambridge Health Alliance. The registered enrollment target is 578 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05116852 has completed, sponsored by Cambridge Health Alliance.
- COMPLETED
- Registry status
- 578 participants
- Enrollment target
Study Summary
This study aims to analyze the needs of those who have lost a loved one to opioid-related death and/or those currently supporting a loved one in treatment for Opioid Use Disorder. Mental health status related to the death or support of a loved one will be assessed through a survey and through the use of several modules of the CAT-MH (computerized adaptive testing-mental health suite) questionnaire.
Primary Outcome
This self-report aim will be assessed via participant survey response asking for recollection of substance use before and after the loss.
Interventions
- OTHER Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 578 participants |
| Start Date | 2022-04-01 |
| Est. Completion | 2024-06-21 |
What the finished NCT05116852 record still lists
NCT05116852 is an observational study that tracks outcomes without assigning an intervention. The registered 578 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Survey is the first listed.
NCT05116852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05116852 about?
NCT05116852 is a clinical study titled "Community and Familial Impacts of the Opioid Crisis". This study aims to analyze the needs of those who have lost a loved one to opioid-related death and/or those currently supporting a loved one in treatment for Opioid Use Disorder. Mental health status related to the death or support of a loved one will be assessed through a survey and through the us...
What is the current status of trial NCT05116852?
This trial is currently completed. The enrollment target is 578 participants. The study started on 2022-04-01. Estimated completion is 2024-06-21.
What interventions are being tested in trial NCT05116852?
The interventions under investigation include: Survey (OTHER).
Who is sponsoring clinical trial NCT05116852?
This trial is sponsored by Cambridge Health Alliance, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07290543 · 578 participants · NA
Web-Based Toolkit to Improve Cancer-Related Emotional Distress and Anxiety in Rural Older Cancer Survivors
- NCT04575935 · 580 participants · Phase 3
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial
- NCT05143177 · 580 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)
- NCT05696353 · 580 participants · Phase 3
Teen Driving Translation Study (NIH)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI